Novavax, Inc. (NVAX) Reports Q3 Loss of $0.03
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $9.00 --0%
Revenue Growth %: -78.2%
Financial Fact:
General and administrative: 13.56M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Revenue Growth %: -78.2%
Financial Fact:
General and administrative: 13.56M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Novavax, Inc. (NASDAQ: NVAX) reported Q3 EPS of ($0.03), $0.02 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $5 million versus the consensus estimate of $5.37 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
- Accenture tumbles 16% on guidance cut; announces Dragos, runZero, NetRise deals
- Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
